Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Magnisense logo — Creating rapid diagnostic solutions for cardiovascular illne...

Magnisense

Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments

Founded 2003 1 employees Venture round Total: $11.70M Health Care

General Information

Company Name Magnisense
Founded Year 2003
Founders / Decision Makers
Team member
Employees 1
Industries Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Magnisense. To contact Magnisense, visit magnisense.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Magnisense compare?

A PDF of Magnisense and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Magnisense soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Magnisense

Magnisense is a health care startup that has been making waves in the industry since its founding in 2003. The company's slogan "Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments" embodies its core mission. In its most recent funding round in October 2018, Magnisense secured a notable €5.00M Venture Round investment. This funding came from a consortium of investors including Noshaq, Provestis SAS, Concorde Capital, Victor Douce, and Minv. The company's innovative approach to emergency diagnostic tests for cardiovascular diseases, leveraging its proprietary MIAtek® technology, has captured the attention and investment of these prominent players in the industry.

Business keywords: cardiovascular diagnostics, emergency diagnostics, MIAtek® technology, proprietary diagnostic instruments, rapid diagnostics, diagnostic tests, cardiovascular diseases, innovation, healthcare solutions

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €5.00M 5
Noshaq Provestis SAS Concorde Capital
Noshaq, Provestis SAS +3
26 Oct 2018
Venture Round €5.50M 2
Provestis SAS Concorde Capital
Provestis SAS, Concorde Capital
27 Nov 2015
Grant €1.20M 1
Bpifrance
Bpifrance
02 Feb 2015

Magnisense Alternatives & Competitors

View All Alternatives
Magnisense vs
bioMérieux
bioMérieux France

We help make the world a healthier place

13122 employees
Biotechnology, Health Care
Magnisense vs
Cor.Sync
Cor.Sync

Empowering rapid and accurate decisions for ischemic cardiovascular emergencies with an advanced dia...

Pre-Seed
11-50 employees
Biotechnology, Health Care
Magnisense vs
ALiA BioTech
ALiA BioTech Hong Kong S.a.r.

Accurate Assay Anywhere

31 employees
Biotechnology, Health Care
View all alternatives

FAQ About Magnisense

Creating rapid diagnostic solutions for cardiovascular illnesses through proprietary MIAtek® technology and advanced diagnostic instruments
Magnisense was founded in 2003.
Magnisense operates in Health Care. Its work centres on cardiovascular diagnostics, emergency diagnostics, MIAtek® technology and proprietary diagnostic instruments.
Magnisense has approximately 1 employees.
Magnisense has completed 3 funding rounds, raising a total of $11.70M. The latest funding stage is Venture round.
Top alternatives and competitors to Magnisense include bioMérieux, Cor.Sync, ALiA BioTech , Zymeron Corporation, First Light Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Magnisense and bioMérieux are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Magnisense, https://bouncewatch.com/company/magnisense, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout